0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Molecular Point-of-Care Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-6I14647
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Molecular Point of Care Testing Market Research Report 2023
BUY CHAPTERS

Global Molecular Point-of-Care Testing Market Research Report 2025

Code: QYRE-Auto-6I14647
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Molecular Point-of-Care Testing Market Size

The global market for Molecular Point-of-Care Testing was valued at US$ 7765 million in the year 2024 and is projected to reach a revised size of US$ 10660 million by 2031, growing at a CAGR of 4.7% during the forecast period.

Molecular Point-of-Care Testing Market

Molecular Point-of-Care Testing Market

Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions. Molecular POCT involves the use of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), to detect and identify specific genetic material or biomarkers associated with diseases or infections.
Here are some key factors influencing the growth of the global molecular POCT market:
Increasing demand for rapid and accurate diagnostic testing: The need for rapid and accurate diagnostic testing is driving the growth of the molecular POCT market. Molecular POCT offers advantages such as rapid turnaround time, portability, and the ability to provide accurate results at the point of care, eliminating the need for sample transportation to centralized laboratories. This is particularly beneficial in emergency and critical care settings, where timely diagnosis is crucial for effective patient management.
Technological advancements in molecular diagnostics: Molecular diagnostic technologies have witnessed significant advancements in recent years, enabling the development of portable, user-friendly, and easy-to-operate molecular POCT devices. These devices offer rapid and reliable results, making them suitable for use in various healthcare settings, including hospitals, clinics, ambulatory care centers, and remote or resource-limited areas. Technological advancements continue to drive the growth of the molecular POCT market.
Rising prevalence of infectious diseases: The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections (STIs), and gastrointestinal infections, remains significant. Molecular POCT plays a crucial role in the rapid detection and identification of pathogens responsible for these infections. The increasing prevalence of infectious diseases, coupled with the need for early diagnosis and treatment, is boosting the demand for molecular POCT solutions.
Growing focus on personalized medicine: Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Molecular POCT plays a vital role in enabling personalized medicine by providing rapid and accurate genetic testing at the point of care. These tests help identify genetic variations, mutations, or biomarkers that can guide treatment decisions and improve patient outcomes. The growing focus on personalized medicine is driving the adoption of molecular POCT.
COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly accelerated the demand for molecular POCT. Rapid and accurate testing for SARS-CoV-2, the virus responsible for COVID-19, has been crucial in controlling the spread of the disease and managing patient care effectively. Molecular POCT devices, such as rapid antigen tests and molecular NAATs, have been widely used for COVID-19 testing in various healthcare settings.
The global molecular POCT market can be segmented based on technology (PCR, NAATs, hybridization, and others), application (infectious diseases, oncology, genetics, and others), end-user (hospitals, clinics, ambulatory care centers, research institutes, and others), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).
In summary, the global molecular POCT market is driven by the increasing demand for rapid and accurate diagnostic testing, technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, the growing focus on personalized medicine, and the impact of the COVID-19 pandemic. Molecular POCT offers the advantage of providing rapid and accurate results at the point of care, enabling timely and appropriate patient management. The market is expected to witness significant growth as the demand for portable and user-friendly molecular diagnostic solutions continues to rise.
This report aims to provide a comprehensive presentation of the global market for Molecular Point-of-Care Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Point-of-Care Testing.
The Molecular Point-of-Care Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Point-of-Care Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Point-of-Care Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Molecular Point-of-Care Testing Market Report

Report Metric Details
Report Name Molecular Point-of-Care Testing Market
Accounted market size in year US$ 7765 million
Forecasted market size in 2031 US$ 10660 million
CAGR 4.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Polymerase Chain Reaction (PCR)
  • Loop-mediated Isothermal Amplification (LAMP)
  • Nucleic Acid Sequence-based Amplification (NASBA)
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Molecular Diagnostics, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, bioMérieux, Inc., Hologic, Inc., Meridian Bioscience, Inc., Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc., Veramarx, XCR Diagnostics, Zhejiang Orient Gene Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Molecular Point-of-Care Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Molecular Point-of-Care Testing Market growing?

Ans: The Molecular Point-of-Care Testing Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the Molecular Point-of-Care Testing Market size in 2031?

Ans: The Molecular Point-of-Care Testing Market size in 2031 will be US$ 10660 million.

Who are the main players in the Molecular Point-of-Care Testing Market report?

Ans: The main players in the Molecular Point-of-Care Testing Market are Roche Molecular Diagnostics, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, bioMérieux, Inc., Hologic, Inc., Meridian Bioscience, Inc., Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc., Veramarx, XCR Diagnostics, Zhejiang Orient Gene Biotech

What are the Application segmentation covered in the Molecular Point-of-Care Testing Market report?

Ans: The Applications covered in the Molecular Point-of-Care Testing Market report are Infectious Diseases, Genetic Disorders, Pregnancy Testing, Diagnosis of Cancer, Pharmacogenomics

What are the Type segmentation covered in the Molecular Point-of-Care Testing Market report?

Ans: The Types covered in the Molecular Point-of-Care Testing Market report are Polymerase Chain Reaction (PCR), Loop-mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence-based Amplification (NASBA)

Recommended Reports

Point-of-Care Diagnostics

POCT Devices & Analyzers

Molecular & Rapid Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Point-of-Care Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Loop-mediated Isothermal Amplification (LAMP)
1.2.4 Nucleic Acid Sequence-based Amplification (NASBA)
1.3 Market by Application
1.3.1 Global Molecular Point-of-Care Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Diseases
1.3.3 Genetic Disorders
1.3.4 Pregnancy Testing
1.3.5 Diagnosis of Cancer
1.3.6 Pharmacogenomics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Point-of-Care Testing Market Perspective (2020-2031)
2.2 Global Molecular Point-of-Care Testing Growth Trends by Region
2.2.1 Global Molecular Point-of-Care Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Point-of-Care Testing Historic Market Size by Region (2020-2025)
2.2.3 Molecular Point-of-Care Testing Forecasted Market Size by Region (2026-2031)
2.3 Molecular Point-of-Care Testing Market Dynamics
2.3.1 Molecular Point-of-Care Testing Industry Trends
2.3.2 Molecular Point-of-Care Testing Market Drivers
2.3.3 Molecular Point-of-Care Testing Market Challenges
2.3.4 Molecular Point-of-Care Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Point-of-Care Testing Players by Revenue
3.1.1 Global Top Molecular Point-of-Care Testing Players by Revenue (2020-2025)
3.1.2 Global Molecular Point-of-Care Testing Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Point-of-Care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Point-of-Care Testing Revenue
3.4 Global Molecular Point-of-Care Testing Market Concentration Ratio
3.4.1 Global Molecular Point-of-Care Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Point-of-Care Testing Revenue in 2024
3.5 Global Key Players of Molecular Point-of-Care Testing Head office and Area Served
3.6 Global Key Players of Molecular Point-of-Care Testing, Product and Application
3.7 Global Key Players of Molecular Point-of-Care Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Point-of-Care Testing Breakdown Data by Type
4.1 Global Molecular Point-of-Care Testing Historic Market Size by Type (2020-2025)
4.2 Global Molecular Point-of-Care Testing Forecasted Market Size by Type (2026-2031)
5 Molecular Point-of-Care Testing Breakdown Data by Application
5.1 Global Molecular Point-of-Care Testing Historic Market Size by Application (2020-2025)
5.2 Global Molecular Point-of-Care Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Point-of-Care Testing Market Size (2020-2031)
6.2 North America Molecular Point-of-Care Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Point-of-Care Testing Market Size by Country (2020-2025)
6.4 North America Molecular Point-of-Care Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Point-of-Care Testing Market Size (2020-2031)
7.2 Europe Molecular Point-of-Care Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Point-of-Care Testing Market Size by Country (2020-2025)
7.4 Europe Molecular Point-of-Care Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Point-of-Care Testing Market Size (2020-2031)
8.2 Asia-Pacific Molecular Point-of-Care Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Point-of-Care Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Point-of-Care Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Point-of-Care Testing Market Size (2020-2031)
9.2 Latin America Molecular Point-of-Care Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Point-of-Care Testing Market Size by Country (2020-2025)
9.4 Latin America Molecular Point-of-Care Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Point-of-Care Testing Market Size (2020-2031)
10.2 Middle East & Africa Molecular Point-of-Care Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Point-of-Care Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Point-of-Care Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Molecular Diagnostics
11.1.1 Roche Molecular Diagnostics Company Details
11.1.2 Roche Molecular Diagnostics Business Overview
11.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Introduction
11.1.4 Roche Molecular Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.1.5 Roche Molecular Diagnostics Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Molecular Point-of-Care Testing Introduction
11.2.4 Roche Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.2.5 Roche Diagnostics Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Molecular Point-of-Care Testing Introduction
11.3.4 Abbott Laboratories Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Molecular Point-of-Care Testing Introduction
11.4.4 Danaher Corporation Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.4.5 Danaher Corporation Recent Development
11.5 bioMérieux, Inc.
11.5.1 bioMérieux, Inc. Company Details
11.5.2 bioMérieux, Inc. Business Overview
11.5.3 bioMérieux, Inc. Molecular Point-of-Care Testing Introduction
11.5.4 bioMérieux, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.5.5 bioMérieux, Inc. Recent Development
11.6 Hologic, Inc.
11.6.1 Hologic, Inc. Company Details
11.6.2 Hologic, Inc. Business Overview
11.6.3 Hologic, Inc. Molecular Point-of-Care Testing Introduction
11.6.4 Hologic, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.6.5 Hologic, Inc. Recent Development
11.7 Meridian Bioscience, Inc.
11.7.1 Meridian Bioscience, Inc. Company Details
11.7.2 Meridian Bioscience, Inc. Business Overview
11.7.3 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Introduction
11.7.4 Meridian Bioscience, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.7.5 Meridian Bioscience, Inc. Recent Development
11.8 Saw Diagnostics
11.8.1 Saw Diagnostics Company Details
11.8.2 Saw Diagnostics Business Overview
11.8.3 Saw Diagnostics Molecular Point-of-Care Testing Introduction
11.8.4 Saw Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.8.5 Saw Diagnostics Recent Development
11.9 Siemens Healthineer
11.9.1 Siemens Healthineer Company Details
11.9.2 Siemens Healthineer Business Overview
11.9.3 Siemens Healthineer Molecular Point-of-Care Testing Introduction
11.9.4 Siemens Healthineer Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.9.5 Siemens Healthineer Recent Development
11.10 Sona Nanotech
11.10.1 Sona Nanotech Company Details
11.10.2 Sona Nanotech Business Overview
11.10.3 Sona Nanotech Molecular Point-of-Care Testing Introduction
11.10.4 Sona Nanotech Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.10.5 Sona Nanotech Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Details
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Molecular Point-of-Care Testing Introduction
11.11.4 T2 Biosystems Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.11.5 T2 Biosystems Recent Development
11.12 Talis Biomedical
11.12.1 Talis Biomedical Company Details
11.12.2 Talis Biomedical Business Overview
11.12.3 Talis Biomedical Molecular Point-of-Care Testing Introduction
11.12.4 Talis Biomedical Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.12.5 Talis Biomedical Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Veramarx
11.14.1 Veramarx Company Details
11.14.2 Veramarx Business Overview
11.14.3 Veramarx Molecular Point-of-Care Testing Introduction
11.14.4 Veramarx Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.14.5 Veramarx Recent Development
11.15 XCR Diagnostics
11.15.1 XCR Diagnostics Company Details
11.15.2 XCR Diagnostics Business Overview
11.15.3 XCR Diagnostics Molecular Point-of-Care Testing Introduction
11.15.4 XCR Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.15.5 XCR Diagnostics Recent Development
11.16 Zhejiang Orient Gene Biotech
11.16.1 Zhejiang Orient Gene Biotech Company Details
11.16.2 Zhejiang Orient Gene Biotech Business Overview
11.16.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Introduction
11.16.4 Zhejiang Orient Gene Biotech Revenue in Molecular Point-of-Care Testing Business (2020-2025)
11.16.5 Zhejiang Orient Gene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Molecular Point-of-Care Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polymerase Chain Reaction (PCR)
 Table 3. Key Players of Loop-mediated Isothermal Amplification (LAMP)
 Table 4. Key Players of Nucleic Acid Sequence-based Amplification (NASBA)
 Table 5. Global Molecular Point-of-Care Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Molecular Point-of-Care Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Molecular Point-of-Care Testing Market Share by Region (2020-2025)
 Table 9. Global Molecular Point-of-Care Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Molecular Point-of-Care Testing Market Share by Region (2026-2031)
 Table 11. Molecular Point-of-Care Testing Market Trends
 Table 12. Molecular Point-of-Care Testing Market Drivers
 Table 13. Molecular Point-of-Care Testing Market Challenges
 Table 14. Molecular Point-of-Care Testing Market Restraints
 Table 15. Global Molecular Point-of-Care Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Molecular Point-of-Care Testing Market Share by Players (2020-2025)
 Table 17. Global Top Molecular Point-of-Care Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point-of-Care Testing as of 2024)
 Table 18. Ranking of Global Top Molecular Point-of-Care Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Molecular Point-of-Care Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Molecular Point-of-Care Testing, Headquarters and Area Served
 Table 21. Global Key Players of Molecular Point-of-Care Testing, Product and Application
 Table 22. Global Key Players of Molecular Point-of-Care Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Molecular Point-of-Care Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Molecular Point-of-Care Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Molecular Point-of-Care Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Molecular Point-of-Care Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Molecular Point-of-Care Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Molecular Point-of-Care Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Molecular Point-of-Care Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Molecular Point-of-Care Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Molecular Point-of-Care Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Molecular Point-of-Care Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Molecular Point-of-Care Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Molecular Point-of-Care Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Molecular Point-of-Care Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Molecular Point-of-Care Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Molecular Point-of-Care Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Molecular Point-of-Care Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Molecular Point-of-Care Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Molecular Point-of-Care Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Roche Molecular Diagnostics Company Details
 Table 48. Roche Molecular Diagnostics Business Overview
 Table 49. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product
 Table 50. Roche Molecular Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 51. Roche Molecular Diagnostics Recent Development
 Table 52. Roche Diagnostics Company Details
 Table 53. Roche Diagnostics Business Overview
 Table 54. Roche Diagnostics Molecular Point-of-Care Testing Product
 Table 55. Roche Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 56. Roche Diagnostics Recent Development
 Table 57. Abbott Laboratories Company Details
 Table 58. Abbott Laboratories Business Overview
 Table 59. Abbott Laboratories Molecular Point-of-Care Testing Product
 Table 60. Abbott Laboratories Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 61. Abbott Laboratories Recent Development
 Table 62. Danaher Corporation Company Details
 Table 63. Danaher Corporation Business Overview
 Table 64. Danaher Corporation Molecular Point-of-Care Testing Product
 Table 65. Danaher Corporation Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 66. Danaher Corporation Recent Development
 Table 67. bioMérieux, Inc. Company Details
 Table 68. bioMérieux, Inc. Business Overview
 Table 69. bioMérieux, Inc. Molecular Point-of-Care Testing Product
 Table 70. bioMérieux, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 71. bioMérieux, Inc. Recent Development
 Table 72. Hologic, Inc. Company Details
 Table 73. Hologic, Inc. Business Overview
 Table 74. Hologic, Inc. Molecular Point-of-Care Testing Product
 Table 75. Hologic, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 76. Hologic, Inc. Recent Development
 Table 77. Meridian Bioscience, Inc. Company Details
 Table 78. Meridian Bioscience, Inc. Business Overview
 Table 79. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product
 Table 80. Meridian Bioscience, Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 81. Meridian Bioscience, Inc. Recent Development
 Table 82. Saw Diagnostics Company Details
 Table 83. Saw Diagnostics Business Overview
 Table 84. Saw Diagnostics Molecular Point-of-Care Testing Product
 Table 85. Saw Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 86. Saw Diagnostics Recent Development
 Table 87. Siemens Healthineer Company Details
 Table 88. Siemens Healthineer Business Overview
 Table 89. Siemens Healthineer Molecular Point-of-Care Testing Product
 Table 90. Siemens Healthineer Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 91. Siemens Healthineer Recent Development
 Table 92. Sona Nanotech Company Details
 Table 93. Sona Nanotech Business Overview
 Table 94. Sona Nanotech Molecular Point-of-Care Testing Product
 Table 95. Sona Nanotech Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 96. Sona Nanotech Recent Development
 Table 97. T2 Biosystems Company Details
 Table 98. T2 Biosystems Business Overview
 Table 99. T2 Biosystems Molecular Point-of-Care Testing Product
 Table 100. T2 Biosystems Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 101. T2 Biosystems Recent Development
 Table 102. Talis Biomedical Company Details
 Table 103. Talis Biomedical Business Overview
 Table 104. Talis Biomedical Molecular Point-of-Care Testing Product
 Table 105. Talis Biomedical Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 106. Talis Biomedical Recent Development
 Table 107. Thermo Fisher Scientific Inc. Company Details
 Table 108. Thermo Fisher Scientific Inc. Business Overview
 Table 109. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product
 Table 110. Thermo Fisher Scientific Inc. Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 111. Thermo Fisher Scientific Inc. Recent Development
 Table 112. Veramarx Company Details
 Table 113. Veramarx Business Overview
 Table 114. Veramarx Molecular Point-of-Care Testing Product
 Table 115. Veramarx Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 116. Veramarx Recent Development
 Table 117. XCR Diagnostics Company Details
 Table 118. XCR Diagnostics Business Overview
 Table 119. XCR Diagnostics Molecular Point-of-Care Testing Product
 Table 120. XCR Diagnostics Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 121. XCR Diagnostics Recent Development
 Table 122. Zhejiang Orient Gene Biotech Company Details
 Table 123. Zhejiang Orient Gene Biotech Business Overview
 Table 124. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product
 Table 125. Zhejiang Orient Gene Biotech Revenue in Molecular Point-of-Care Testing Business (2020-2025) & (US$ Million)
 Table 126. Zhejiang Orient Gene Biotech Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Molecular Point-of-Care Testing Picture
 Figure 2. Global Molecular Point-of-Care Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Molecular Point-of-Care Testing Market Share by Type: 2024 VS 2031
 Figure 4. Polymerase Chain Reaction (PCR) Features
 Figure 5. Loop-mediated Isothermal Amplification (LAMP) Features
 Figure 6. Nucleic Acid Sequence-based Amplification (NASBA) Features
 Figure 7. Global Molecular Point-of-Care Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Molecular Point-of-Care Testing Market Share by Application: 2024 VS 2031
 Figure 9. Infectious Diseases Case Studies
 Figure 10. Genetic Disorders Case Studies
 Figure 11. Pregnancy Testing Case Studies
 Figure 12. Diagnosis of Cancer Case Studies
 Figure 13. Pharmacogenomics Case Studies
 Figure 14. Molecular Point-of-Care Testing Report Years Considered
 Figure 15. Global Molecular Point-of-Care Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Molecular Point-of-Care Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Molecular Point-of-Care Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Molecular Point-of-Care Testing Market Share by Players in 2024
 Figure 19. Global Top Molecular Point-of-Care Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point-of-Care Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Molecular Point-of-Care Testing Revenue in 2024
 Figure 21. North America Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Molecular Point-of-Care Testing Market Share by Country (2020-2031)
 Figure 23. United States Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Molecular Point-of-Care Testing Market Share by Country (2020-2031)
 Figure 27. Germany Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Molecular Point-of-Care Testing Market Share by Region (2020-2031)
 Figure 35. China Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Molecular Point-of-Care Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Molecular Point-of-Care Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Molecular Point-of-Care Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Roche Molecular Diagnostics Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 51. Roche Diagnostics Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 52. Abbott Laboratories Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 53. Danaher Corporation Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 54. bioMérieux, Inc. Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 55. Hologic, Inc. Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 56. Meridian Bioscience, Inc. Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 57. Saw Diagnostics Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 58. Siemens Healthineer Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 59. Sona Nanotech Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 60. T2 Biosystems Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 61. Talis Biomedical Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 62. Thermo Fisher Scientific Inc. Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 63. Veramarx Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 64. XCR Diagnostics Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 65. Zhejiang Orient Gene Biotech Revenue Growth Rate in Molecular Point-of-Care Testing Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS